QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
NASDAQ:FLGT

Fulgent Genetics Earnings Date, Estimates, & History

$82.81
-0.22 (-0.26 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$82.52
$85.37
50-Day Range
$77.39
$99.10
52-Week Range
$30.05
$189.89
Volume
202,034 shs
Average Volume
1.15 million shs
Market Capitalization
$2.44 billion
P/E Ratio
4.80
Dividend Yield
N/A
Beta
1.48

Earnings Summary

Upcoming
Earnings Date
Nov. 9
Confirmed

Actual EPS
(Aug. 9)
$2.47
Missed By -$0.07

Consensus EPS
(Aug. 9)
$2.54

Last Year's Q3 EPS
(8/4/2020)
$0.17

Skip Charts & View Estimated and Actual Earnings Data

Fulgent Genetics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Fulgent Genetics Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fulgent Genetics (NASDAQ:FLGT) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211$3.77$3.77$3.77 
Q2 20211$3.31$3.31$3.31 
Q3 20212$1.30$2.82$2.06$
Q4 20212$1.89$2.45$2.17 
FY 20216$10.27$12.35$11.31
Q1 20221$1.74$1.74$1.74 
Q2 20221$1.42$1.42$1.42 
Q3 20221$1.08$1.08$1.08 
Q4 20221$1.02$1.02$1.02 
FY 20224$5.26$5.26$5.26

FLGT Earnings Information

Fulgent Genetics last released its quarterly earnings results on August 9th, 2021. The reported $2.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.54 by $0.07. The firm had revenue of $153.60 million for the quarter, compared to analysts' expectations of $197.34 million. Its revenue for the quarter was up 789.4% on a year-over-year basis. Fulgent Genetics has generated $8.85 earnings per share over the last year ($17.25 diluted earnings per share) and currently has a price-to-earnings ratio of 4.8. Fulgent Genetics has confirmed that its next quarterly earnings report will be published on Tuesday, November 9th, 2021. Fulgent Genetics will be holding an earnings conference call on Tuesday, November 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Fulgent Genetics (NASDAQ:FLGT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
11/9/2021
(Confirmed)
 $1.30       
8/9/20216/30/2021$2.54$2.47($0.07)$2.35$197.34 million$153.60 million    
5/6/20213/31/2021$5.95$6.59+$0.64$6.50$326.46 million$359.43 million  
3/3/202112/31/2020$4.36$6.20+$1.84$6.08$199.38 million$294.98 million  
11/9/2020Q3$0.39$2.08+$1.69$1.92$51.73 million$101.72 million  
8/4/20206/30/2020$0.01$0.17+$0.16$0.20$14.52 million$17.27 million  
5/4/20203/31/2020$0.02($0.03)($0.05)($0.07)$7.69 million$7.75 million  
3/10/202012/31/2019$0.04$0.04$0.01$9.02 million$8.39 million  
11/4/2019Q3 2019$0.01$0.09+$0.08$0.10$8.48 million$10.35 million
8/5/2019Q2 2019($0.04)$0.02+$0.06$0.02$6.42 million$8.42 million  
5/7/20193/31/2019($0.06)($0.09)($0.03)($0.08)$5.46 million$5.37 million  
2/28/2019Q4 2018($0.01)($0.03)($0.02)($0.01)$5.90 million$5.68 million
11/6/2018Q3 2018($0.03)($0.03)($0.03)$5.63 million
8/6/2018Q2 2018($0.03)($0.01)+$0.02($0.02)$4.97 million$5.40 million
5/7/2018Q1 2018($0.04)($0.06)($0.02)($0.05)$4.65 million
2/28/2018Q4 2017($0.03)($0.09)($0.06)($0.08)$5.26 million$4.28 million
11/6/2017Q3 2017($0.05)($0.05)($0.04)$5.52 million$4.50 million
8/7/2017Q2 2017$0.0160$0.02+$0.0040$5.03 million$4.64 million  
5/8/2017Q1 2017$0.03$0.02($0.01)$0.03$5.85 million$5.31 million  
2/27/2017Q416$0.04$0.05+$0.01$0.05$5.99 million$5.85 million  
11/14/2016Q3 2016$0.08($0.44)($0.52)($0.44)$5.16 million$5.01 million
(Earnings results data provided by Zacks Investment Research)












Fulgent Genetics (NASDAQ:FLGT) Earnings Frequently Asked Questions

When is Fulgent Genetics's earnings date?

Fulgent Genetics has confirmed that its next quarterly earnings data will be published on Tuesday, November 9th, 2021. Learn more on FLGT's earnings history

Did Fulgent Genetics beat their earnings estimates last quarter?

In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) missed the analysts' consensus estimate of $2.54 by $0.07 with a reported earnings per share (EPS) of $2.47. Learn more on FLGT's earnings details

How can I listen to Fulgent Genetics's earnings conference call?

The conference call for Fulgent Genetics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Fulgent Genetics's conference call transcript?

The conference call transcript for Fulgent Genetics's latest earnings report can be read online. Read Transcript

How much revenue does Fulgent Genetics generate each year?

Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $421.71 million.

How much profit does Fulgent Genetics generate each year?

Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of $214.31 million. FLGT has generated $8.85 earnings per share over the last four quarters.

What is Fulgent Genetics's price-to-earnings ratio?

Fulgent Genetics (NASDAQ:FLGT) has a trailing price-to-earnings ratio of 4.80.

This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.